Engineered Polymer Nanoparticles: A Potent Weapon Against Cancer. Cervical cancer is the commonest cause of cancer death in women under the age of 50 worldwide, the 8th most common cancer among women in Australia, and is the leading cause of cancer death in Aboriginal women. While a vaccine is available to prevent HPV-mediated disease, it would not impact upon death rates for at least 25 years. The systemic delivery of RNAi offers to best opportunity to solve this problem. The delivery devices w ....Engineered Polymer Nanoparticles: A Potent Weapon Against Cancer. Cervical cancer is the commonest cause of cancer death in women under the age of 50 worldwide, the 8th most common cancer among women in Australia, and is the leading cause of cancer death in Aboriginal women. While a vaccine is available to prevent HPV-mediated disease, it would not impact upon death rates for at least 25 years. The systemic delivery of RNAi offers to best opportunity to solve this problem. The delivery devices will be designed with precision and function to meet the delivery needs in vivo. These polymer structures will be suitable for use in drug and gene delivery providing Australian products with advanced features and capabilities, significantly improving product performance.Read moreRead less
Molecular grafting methods for design of peptide therapeutics. This project has the potential to lead to major economic benefits to Australia via royalty returns from novel drugs. Extra economic benefits derive from a reduction in the cost of treatment of diseases. The development of a new Australian developed peptide drug thus has the potential to lead to multimillion dollar savings to the Australian economy. Finally the project will provide training in state-of-the-art drug design that will e ....Molecular grafting methods for design of peptide therapeutics. This project has the potential to lead to major economic benefits to Australia via royalty returns from novel drugs. Extra economic benefits derive from a reduction in the cost of treatment of diseases. The development of a new Australian developed peptide drug thus has the potential to lead to multimillion dollar savings to the Australian economy. Finally the project will provide training in state-of-the-art drug design that will enhance Australia's pharmaceutical industry generally.Read moreRead less